Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.

Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G.

Bipolar Disord. 2000 Sep;2(3 Pt 2):249-55.

PMID:
11249802
2.

A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.

Vieta E, Manuel Goikolea J, Martínez-Arán A, Comes M, Verger K, Masramon X, Sanchez-Moreno J, Colom F.

J Clin Psychiatry. 2006 Mar;67(3):473-7.

PMID:
16649836
3.

A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.

Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.

Bipolar Disord. 2006 Feb;8(1):75-80.

PMID:
16411983
4.

Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.

Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.

J Clin Psychiatry. 2012 Nov;73(11):1412-9. doi: 10.4088/JCP.11m07388.

PMID:
23218157
5.

Gabapentin as an adjunctive treatment in bipolar disorder.

Young LT, Robb JC, Hasey GM, MacQueen GM, Patelis Siotis I, Marriott M, Joffe RT.

J Affect Disord. 1999 Sep;55(1):73-7.

PMID:
10512610
6.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
7.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group..

J Clin Psychiatry. 2009 Feb;70(2):223-31.

PMID:
19200421
8.

Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.

Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR; Clinical Affairs Product Support Study-168 Investigators..

J Clin Psychiatry. 2006 Nov;67(11):1698-706.

PMID:
17196048
9.

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.

Curr Med Res Opin. 2010 Jun;26(6):1485-96. doi: 10.1185/03007991003779380.

PMID:
20429835
10.

Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?

Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, Akiskal HS.

J Clin Psychopharmacol. 2002 Dec;22(6):584-91.

PMID:
12454558
11.

Gabapentin augmentation therapy in bipolar depression.

Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA.

Bipolar Disord. 2002 Oct;4(5):296-301.

PMID:
12479661
12.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14.

PMID:
17391773
13.

Gabapentin treatment of the non-refractory bipolar spectrum: an open case series.

Ghaemi SN, Goodwin FK.

J Affect Disord. 2001 Jul;65(2):167-71.

PMID:
11356240
14.

Topiramate as add-on treatment for patients with bipolar mania.

Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H, Levin H, Moffa N, Delaney J, Brar JS.

Bipolar Disord. 1999 Sep;1(1):42-53.

PMID:
11256656
15.

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

Bowden CL, Mosolov S, Hranov L, Chen E, Habil H, Kongsakon R, Manfredi R, Lin HN.

Int Clin Psychopharmacol. 2010 Mar;25(2):60-7. doi: 10.1097/YIC.0b013e328333ac1b.

PMID:
20101186
16.

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.

Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H.

Pharmacopsychiatry. 1999 Jul;32(4):136-41. Review.

PMID:
10505483
17.

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):94-9. doi: 10.1016/j.pnpbp.2008.10.012.

PMID:
19007842
19.

Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.

Cabras PL, Hardoy MJ, Hardoy MC, Carta MG.

J Clin Psychiatry. 1999 Apr;60(4):245-8.

PMID:
10221286
20.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
Items per page

Supplemental Content

Support Center